Ying Wang

Ying Wang, PhD, MPH

Environmental public health tracking and surveillance with focus on surveillance and research to identify environmental and genetic risk factors for major birth defects that affect about 3 in 100 babies and are a leading cause of infant mortality in the United States.

The World Within Reach
Ying Wang, PhD, MPH
Assistant Professor

School of Public Health
Department: Environmental Health Sciences

Director, Data Management, Analysis & Research Group (DMAR), Office of Primary Care & Health System Management (OPCHSM), NYSDOH



PhD, Biophysical Chemistry
University at Albany, State University of New York, 1989
MPH, Environmental Epidemiology, 1996

Research Interests

Conduct multi-state collaborative birth defect research projects to identify potential risk factors of birth defect prevalence and mortality. The most current research focuses on program evaluation and population health surveillance on improving quality of care of patients in acute and long-term health care facilities, and developing predictive models for evaluating and forecasting financial health of health care facilities in New York State. 


1) Lopez KN, Nembhard WN, Wang Y, Liu G, Kucik JE, Copeland G, Gilboa SM, Kirby RS, Canfield M.  Birth defect survival for Hispanic subgroups. Birth Defects Res. 2017 Dec 1. doi: 10.1002/bdr2.1157. [Epub ahead of print]

2) Meyer RE, Liu G, Gilboa SM, Ethen MK, Aylsworth AS, Powell CM, Flood TJ, Mai CT, Wang Y, Canfield MA; National Birth Defects Prevention Network. Survival of children with trisomy 13 and trisomy 18: A multi-state population-based study. Am J Med Genet A. 2016;170::825-37.

3) Anders DG, Tang F, BMed,2 Ledneva T, Caggana M, Green NS, Wang Y, Sturman LS. Hydroxyurea use in young children with sickle cell anemia in New York State. Am J Prev Med. 2016; 51(1 Suppl 1): S31-8

4) Wang Y, Liu G, Canfield MA, Mai CT, Gilboa SM, Meyer RE, Anderka M, Copeland GE, Kucik JE,Nembhard WN, Kirby RS; National Birth Defects Prevention Network. Racial/Ethnic Differences in Survival of United States Children with Birth Defects: A Population-Based Study. J Pediatr. 2015; 166:819-26.

5) Wang Y, Liu G, Caggana M, Kennedy J, Zimmerman R, Oyeku SO, Werner EM, Grant AM, Green NS, Grosse SD.  Mortality of New York children with sickle cell disease identified through newborn screening. Genet Med. 2015; 17(6):452-459.

6) Hulihan MM, Feuchtbaum L, Jordan L, Kirby RS,  Snyder A, Young W, Greene Y, Telfair J, Wang Y, Cramer W, Werner EM, Kenney K, Creary M, Grant AM.
State-based surveillance for selected hemoglobinopathies. Genet Med. 2015;17:125-30